Literature DB >> 15331674

Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity.

Alice K Chan1, Nathalie Vergnolle, Morley D Hollenberg, Pierre-Yves von der Weid.   

Abstract

Lymphatic vessels rhythmically constrict to avoid fluid and protein accumulation in the interstitial space. This activity is critical during inflammation to prevent excessive oedema. Lymphatic pumping is intrinsic to the smooth muscle in the vessel wall and is due to the spontaneous occurrence of action potentials, the pacemaker of which is proposed to be spontaneous transient depolarizations (STDs). This function is highly susceptible to the fluid load and modulated by chemical agents, amongst which inflammatory mediators are important players. Activation of proteinase-activated receptors (PARs) has been involved in inflammation and affects vascular smooth muscle tone. The present study aims to investigate the role of PAR2, a member of the PAR family, in lymphatic vessel pumping. RT-PCR experiments revealed that PAR2 message is present in lymphatic vessels of the guinea-pig mesentery. Agonists of PAR2 such as trypsin and the activating peptide, SLIGRL-NH2, caused a decrease in the contractile activity of intraluminally perfused lymphatic vessels. Moreover, intracellular microelectrode recordings from isolated vessels revealed that PAR2 activation hyperpolarized the lymphatic smooth muscle membrane potential and altered STD amplitude and frequency. The decreases in constriction frequency and STD activity as well as the hyperpolarization were dependent on a functional endothelium, not affected by NO synthase or guanylyl-cyclase inhibition, but mimicked by PGE2 and iloprost and blocked by indomethacin (10 microM) and glibenclamide (1 microM). These results show that PAR2 activation alters guinea-pig lymphatic vessel contractile and electrical activity via the production of endothelium-derived cyclo-oxygenase metabolites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331674      PMCID: PMC1665257          DOI: 10.1113/jphysiol.2004.071399

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  45 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 2.  Protease-activated receptors in inflammation, neuronal signaling and pain.

Authors:  N Vergnolle; J L Wallace; N W Bunnett; M D Hollenberg
Journal:  Trends Pharmacol Sci       Date:  2001-03       Impact factor: 14.819

Review 3.  Protease activated receptor 2 and the cardiovascular system.

Authors:  Carla Cicala
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 4.  Review article: lymphatic vessel pumping and inflammation--the role of spontaneous constrictions and underlying electrical pacemaker potentials.

Authors:  P Y von der Weid
Journal:  Aliment Pharmacol Ther       Date:  2001-08       Impact factor: 8.171

5.  Nitric oxide decreases pacemaker activity in lymphatic vessels of guinea pig mesentery.

Authors:  P Y von der Weid; J Zhao; D F Van Helden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

6.  Ca(2+)-activated Cl(-) current in sheep lymphatic smooth muscle.

Authors:  H M Toland; K D McCloskey; K D Thornbury; N G McHale; M A Hollywood
Journal:  Am J Physiol Cell Physiol       Date:  2000-11       Impact factor: 4.249

7.  Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons.

Authors:  David E Reed; Carlos Barajas-Lopez; Graeme Cottrell; Sara Velazquez-Rocha; Olivier Dery; Eileen F Grady; Nigel W Bunnett; Stephen J Vanner
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

8.  Vascular contraction and relaxation to thrombin and trypsin: thrombomodulin preferentially attenuates thrombin-induced contraction.

Authors:  A Bhattacharya; M L Cohen
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

9.  Mechanism of trypsin-induced endothelium-dependent vasorelaxation in the porcine coronary artery.

Authors:  T Nakayama; K Hirano; J Nishimura; S Takahashi; H Kanaide
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

10.  Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists.

Authors:  J R Hamilton; A G Frauman; T M Cocks
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

View more
  10 in total

1.  Mechanisms of VIP-induced inhibition of the lymphatic vessel pump.

Authors:  Pierre-Yves von der Weid; Sonia Rehal; Peter Dyrda; Stewart Lee; Ryan Mathias; Mozibur Rahman; Simon Roizes; Mohammad S Imtiaz
Journal:  J Physiol       Date:  2012-03-25       Impact factor: 5.182

2.  Contraction-initiated NO-dependent lymphatic relaxation: a self-regulatory mechanism in rat thoracic duct.

Authors:  Olga Yu Gasheva; David C Zawieja; Anatoliy A Gashev
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

3.  Gastrointestinal lymphatics in health and disease.

Authors:  J S Alexander; Vijay C Ganta; P A Jordan; Marlys H Witte
Journal:  Pathophysiology       Date:  2010-09

4.  Mesenteric lymphatic vessels adapt to mesenteric venous hypertension by becoming weaker pumps.

Authors:  R M Dongaonkar; T L Nguyen; C M Quick; C L Heaps; J Hardy; G A Laine; E Wilson; R H Stewart
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-17       Impact factor: 3.619

5.  Electrophysiological properties of rat mesenteric lymphatic vessels and their regulation by stretch.

Authors:  Pierre-Yves von der Weid; Stewart Lee; Mohammad S Imtiaz; David C Zawieja; Michael J Davis
Journal:  Lymphat Res Biol       Date:  2014-05-27       Impact factor: 2.589

6.  Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R.

Authors:  Sanjukta Chakraborty; Zhanna Nepiyushchikh; Michael J Davis; David C Zawieja; Mariappan Muthuchamy
Journal:  Microcirculation       Date:  2011-01       Impact factor: 2.628

Review 7.  Lymphatic system: a vital link between metabolic syndrome and inflammation.

Authors:  Sanjukta Chakraborty; Scott Zawieja; Wei Wang; David C Zawieja; Mariappan Muthuchamy
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 8.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

Review 9.  KATP channels in lymphatic function.

Authors:  Michael J Davis; Hae Jin Kim; Colin G Nichols
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-04       Impact factor: 5.282

10.  Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels.

Authors:  Sonia Rehal; Pauline Blanckaert; Simon Roizes; Pierre-Yves von der Weid
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.